Financial intelligence for Asia's healthcare markets
Remember me:

News articles    

Healthcare Partners Holdings, the dissent shareholders of Abano Healthcare Group, have slunk off after selling down their 19% stake in the NZX-listed specialist medical investment firm for around NZ$36.7 million (US$26.6 million).
The bonds and loans of RHT Health Trust are back on course. As expected, the consent solicitation for approval to waive a change-of-shareholding event on its outstanding 4.5% bonds of S$120 million (US$88 million) due 2018 has passed without amendment, and it has obtained the consent of all lenders to waive the events of cross default on its banking facilities.
Shanghai-based Ankon Technologies, which develops technology to detect stomach cancer, has raised US$100 million funding led by SB China Venture Capital. It was joined by Dazhong Investment, Youshi Capital and Tongsheng Capital.
A set of good annual results saw shares in Australian hearing implant manufacturer Cochlear trade up more than 7% yesterday.
SGX-listed healthcare provider Healthway Medical Corporation has appointed Dominic Er as interim chief executive officer. This follows the shock resignation of Veronica Chan at the start of the month. She had been appointed in only September last year after joining as general manager in June.
Thanks to acquisitions at the start of the year, IVD and medical imaging company Yestar Healthcare has produced a strong set of half yearly figures.
Beijing-based paediatric healthcare provider New Century Healthcare has released a positive profit alert for the first half of the year.
Shares in Aveo Group shot up almost 10% after profits more than doubled at the Australian retirement village owner and operator.
Full year profits at international pathology, imaging and medical centres operator Sonic Healthcare have been hit by the rise of the Australian dollar.
Lilly Asia Ventures, which makes venture capital investments in Asia for global pharmaceutical giant Eli Lilly and Company, has closed LAV Biosciences Fund IV, its fourth fund. It took only two months to reach the hard cap of US$450 million.

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia


HealthInvestor Asia Summit



Words and tweets from the White House continue to unsettle markets. “Wall Street dropped, while US Treasuries advanced, amid concern that US president Donald Trump has derailed his chances of implementing the policies that had been seen as good for business and economic growth,” said Julie Wu at Equity Investment Advisers in Auckland this morning. Sentiment was not helped by rumours that White House economic advisor Gary Cohn could resign, which will completely knock out any chance of the president pushing through an economic reform plan. Asian markets broadly sold off, with the Nikkei declining 1.1% to a three-month low as the yen appreciated 0.20% against the US dollar. Investors were also unsettled by the terrorist attack in Barcelona and an attempted linked attack in Cambrils, Spain. The ASX, the Hang Seng and the Shanghai Composite all posted declines.



HealthInvestor Asia twitter feed


HealthInvestor UK